Review of diagnostic biomarkers in autoimmune pancreatitis: Where are we now?

12Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Autoimmune pancreatitis (AIP) is a pancreatic manifestation of an IgG4-related disease (IgG4-RD). AIP lacks disease-specific biomarkers, and therefore, it is difficult to distinguish AIP from malignancies, especially pancreatic cancer. In this review, we have summarized the latest findings on potential diagnostic biomarkers for AIP. Many investigations have been conducted, but no specific biomarkers for AIP are identified. Therefore, further studies are required to identify accurate diagnostic biomarkers for AIP.

Cite

CITATION STYLE

APA

Yokode, M., Shiokawa, M., & Kodama, Y. (2021). Review of diagnostic biomarkers in autoimmune pancreatitis: Where are we now? Diagnostics. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/diagnostics11050770

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free